PPL 36.71 PPL Corp $PPL Hit a 52 week high of 36.81

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
PPL 36.71 PPL Corp $PPL Hit a 52 week high of 36.81 Currently at 36.71 -0.07 -0.19% With a day low of 36.58 and a total volume of 81,306.

PPL PPL Corp Recent Headline News

PPL Corp. A Pick Of Choice For Investors
Horizon Investments - at Seeking Alpha - Mon Nov 10, 12:41PM CST

AEP: 57.94 (-0.44), EXC: 37.65 (+0.05), DUK: 82.54 (-0.27), PPL: 36.56 (-0.22)

Danger Lurking in PPL Stock Dividend Payout Ratio Analysis?
Dan Caplinger, The Motley Fool - Motley Fool - Mon Nov 10, 9:04AM CST
Source: PPL. Dividend investors gravitate to stocks that will provide them with the reliable income that they need in order to support their standard of living. Yet in order for a company to sustain its dividend payouts over the long run, it needs...
PPL: 36.56 (-0.22)

Northeast Utilities (NU) Misses on Q3 Earnings & Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 10:30AM CST
In the third quarter of 2014, Northeast Utilities' (NU) earnings per share and revenues missed the Zacks Consensus Estimate.
SE: 39.42 (+0.10), PPL: 36.56 (-0.22), SEP: 56.10 (-0.15), NU: 50.56 (-0.17)

PPL's Presentation to be Webcast from Edison Electric Institute's Annual Financial Conference
PR Newswire - Thu Nov 06, 1:28PM CST
PPL Corporation (NYSE: PPL) Chairman, President and Chief Executive Officer William H. Spence will outline the company's strategy and general business outlook to investors and financial analysts at the Edison Electric Institute's 49th annual financial conference in Dallas, Texas, on Thursday, Nov. 13, at 10:30 a.m. Central time.
PPL: 36.56 (-0.22)

Westar Energy Beats Q3 Earnings on Higher Electric Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 10:00AM CST
Westar Energy's (WR) earnings and revenues in the third quarter 2014 were ahead of the Zacks Consensus Estimate.
WR: 39.28 (+0.07), FE: 37.28 (-0.07), PPL: 36.56 (-0.22), ALE: 52.18 (-0.47)

SmarTrend Watching for Potential Pullback in Shares of PPL After 4.15% Gain
Comtex SmarTrend(R) - Wed Nov 05, 4:01PM CST
PPL (NYSE PL) traded in a range yesterday that spanned from a low of $35.23 to a high of $36.42. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $35.42 on volume of 11.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PPL: 36.56 (-0.22)

After Yesterday's Rally of 4.15% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Nov 05, 4:00PM CST
PPL (NYSE PL) traded in a range yesterday that spanned from a low of $35.23 to a high of $36.42. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $35.42 on volume of 11.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PPL: 36.56 (-0.22)

One Reason NRG Energy (NRG) Stock Is Climbing Today
at The Street - Wed Nov 05, 1:55PM CST
NRG Energy (NRG) stock is rising after benchmark U.S. crude prices gained, and the company reported a rise in its 2014 third quarter earnings results.
NEE: 104.94 (-0.67), FE: 37.28 (-0.07), PPL: 36.56 (-0.22), NRG: 33.19 (+0.02)

NRG Energy (NRG) Misses Q3 Earnings Estimates, Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:18PM CST
In the third quarter of 2014, NRG Energy, Inc.'s (NRG) earnings per share missed the Zacks Consensus Estimate while revenues beat the same.
EXC: 37.65 (+0.05), PPL: 36.56 (-0.22), NYLD: 48.39 (-0.11), NRG: 33.19 (+0.02)

PPL cutting 450 jobs ahead of plant spinoff
AP - Wed Nov 05, 9:49AM CST
ALLENTOWN, Pa. (AP) — A Pennsylvania utility says it's eliminating 450 jobs as part of cost-cutting stemming from a planned spinoff of its competitive generation business.
PPL: 36.56 (-0.22)

PPL Corporation's (PPL) CEO Bill Spence on Q3 2014 Results -- Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 1:33PM CST

PPL: 36.56 (-0.22)

PPL Corporation (PPL) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Tue Nov 04, 11:37AM CST
The following PPL Corporation (PPL) conference call took place on November 4, 2014, 08:30 AM ET. This is a transcript of that earnings call:
PPL: 36.56 (-0.22)

PPL Corp. (PPL) Beats Q3 Earnings Estimates, Ups Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 9:50AM CST
In the third quarter of 2014, PPL Corporation's (PPL) earnings per share and revenues surpassed the Zacks Consensus Estimate.
EXC: 37.65 (+0.05), PEG: 41.02 (-0.44), PPL: 36.56 (-0.22), EIX: 63.04 (-0.04)

Electric Utilities Stocks Technical Report - American Electric Power, PPL Corp., Edison Intl., Centrais Eletricas Brasileiras, and Great Plains Energy
PR Newswire - Tue Nov 04, 8:30AM CST
Investor-Edge has initiated coverage on the following equities: American Electric Power Company Inc. (NYSE: AEP), PPL Corporation (NYSE: PPL), Edison International (NYSE: EIX), Centrais Eletricas Brasileiras S.A. (NYSE: EBR), and Great Plains Energy Inc. (NYSE: GXP). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Monday, November 03, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,366.24, down 0.14% and the NASDAQ Composite closed at 4,638.91, up 0.18%. The S&P 500 finished the session 0.01% lower at 2,017.81. During the trading session, seven out of ten sectors finished on a higher note. The S&P 500 Utilities Sector Index ended the day at 232.53, up 0.69%, with the index gaining 10.59% in the previous three months. Register for your complimentary reports on these five stocks at:
AEP: 57.94 (-0.44), GXP: 27.07 (-0.08), PPL: 36.56 (-0.22), EBR: 2.40 (+0.01), EIX: 63.04 (-0.04)

Quarterly Earnings, Customer Alert Warning, Project Updates, and Earnings Schedules - Research Reports on Exelon, Duke Energy, Dominion, PPL and Edison
PR Newswire - Tue Nov 04, 7:30AM CST
Today, Analysts Review released its research reports regarding Exelon Corporation (NYSE: EXC), Duke Energy Corporation (NYSE: DUK), Dominion Resources, Inc. (NYSE: D), PPL Corporation (NYSE: PPL) and Edison International (NYSE: EIX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7664-100free.
D: 73.91 (-0.45), DUK: 82.55 (-0.26), EXC: 37.65 (+0.05), PPL: 36.56 (-0.22), EIX: 63.04 (-0.04)

PPL beats 3Q profit forecasts
Automated Insights - Tue Nov 04, 6:21AM CST
ALLENTOWN, Pa. (AP) _ PPL Corp. (PPL) on Tuesday reported earnings of $497 million in its third quarter.
PPL: 36.56 (-0.22)

PPL beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 6:01AM CST

PPL: 36.56 (-0.22)

PPL Corporation Reports Third-Quarter Earnings
PR Newswire - Tue Nov 04, 5:57AM CST
PPL Corporation (NYSE: PPL) announced on Tuesday (11/4) third-quarter 2014 reported earnings of $497 million, or $0.74 per share, an increase from $410 million, or $0.62 per share, a year ago. For the first nine months of 2014, PPL's reported earnings were $1.04 billion, or $1.57 per share, compared with $1.23 billion, or $1.90 per share, in the first nine months of 2013.
PPL: 36.56 (-0.22)

What to Expect When PPL Corp. (PPL) Reports Third-Quarter Earnings Tuesday
at The Street - Mon Nov 03, 11:06AM CST
PPL Corp. (PPL) is gaining Monday ahead of the electric utility company's earnings report on Tuesday morning.
PPL: 36.56 (-0.22)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 361

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 232

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 507

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 62

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 223

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 175

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 57

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 233

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading

Top 5 Most Recently Viewed Articles

Emerie.ai: Transforming Customer Experience in FinTech

Updated Category News Views 489

Introducing Emerie.ai Emerie.ai, formerly known as ENACOMM Financial Services, Inc., represents a significant step forward in the FinTech arena. The company has undergone a rebranding to better reflect its core offering—an Intelligent Virtual Assistant (IVA)—which utilizes cutting-edge artificial intelligence technology. As customer service standards continue to rise,...

Continue Reading
Explore the Groundbreaking JumpCloudLand Conference 2026

Updated Category News Views 183

JumpCloudLand Conference: A New Era for IT Professionals JumpCloud Inc. has launched a remarkable initiative—JumpCloudLand, a comprehensive virtual conference tailored for IT professionals. This dynamic event is set to take place on February 10, 2026, providing a unique opportunity for IT leaders globally to gather and enhance their skills. The nature of IT is...

Continue Reading
General Shale Introduces an Innovative Brick Collection for 2026

Updated Category News Views 220

Innovative Brick Collection from General Shale for 2026 Transforming Spaces with Stylish Brick Designs For years, clay brick has symbolized durability and tradition. General Shale is now revolutionizing brickwork by introducing a new collection that transforms brick into a modern art form, showcasing a range of sizes, textures, and colors. Their contemporary lineup...

Continue Reading
Revolutionary Breakthrough in Gene Therapy for SCN2A Disorders

Updated Category News Views 269

Groundbreaking Research at UCSF Offers New Hope The laboratories led by Dr. Kevin Bender and Dr. Nadav Ahituv have made significant strides in gene therapy through groundbreaking research. Their recent study unveils a compelling new approach to address SCN2A haploinsufficiency, a critical factor linked to various neurodevelopmental disorders and early-onset epilepsy. This...

Continue Reading
FirstEnergy's New Leadership: Brian Tierney Takes Charge

Updated Category News Views 476

FirstEnergy Corporation Welcomes Brian Tierney as Chair FirstEnergy Corp. (NYSE: FE) has announced the appointment of its President and Chief Executive Officer, Brian X. Tierney, as the new Chair of the Board. This change takes effect on a future date, bringing fresh leadership to the company valued at $22.6 billion. Tierney, who has been in the role of President and CEO...

Continue Reading